About Us
Mission & History
Business Model
Donors
Governance
Stakeholders
Scientific Advisors
Team
Jobs
Why New Drugs Now?
Threat of TB
Outdated Treatment
TB-HIV
Drug-Resistant TB
The Poverty Cycle
Developing New Treatments
Portfolio
Critical Path to TB Regimens
Strategic Initiatives
Regulatory Engagement
Adoption & Availability
AAA Mandate
Working with Constituencies
Engaging Policymakers
Laying the Groundwork
NewsCenter
News from the TB Alliance
News About Us
Latest TB News
Publications
Multimedia
Resources
Events
Media Support
Contact Us
1
2
3
-
Next
Global tuberculosis drug development pipeline: the need and the reality
ZHENKUN MA, CHRISTIAN LIENHARDT, HELEN MCILLERON, ANDREW J NUNN, XIEXIU WANG
Lancet Series on Tuberculosis, May 19, 2010
Tuberculosis drug development: Progress, challenges, and the road ahead
ANN M. GINSBERG
Tuberculosis, 4/20/2010
Synthesis and Structure-activity Relationships of Antitubercular 2-Nitroimidazooxazines Bearing Heterocyclic Side Chains
SUTHERLAND, H.S. ET AL
Journal of Medicinal Chemistry. December 24, 2009
Synthesis and Structure-Activity Studies of Biphenyl Analogues of the Tuberculosis Drug (6S)-2-Nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (PA-824)
PALMER, B.D., ET AL
Journal of Medicinal Chemistry. 2010, 53, 282–294
Handbook of anti-tuberculosis agents
GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT
Tuberculosis. 2008. 88: 85-169
Assessment of global capacity to conduct tuberculosis drug development trials; do we have what it takes?
C, VAN NIEKERK, A. GINSBERG
International Journal of Tuberculosis and Lung Disease. 13(11):1367-1372
The ethics of non-inferiority trials
NUNN, A.J., ET AL
Lancet. 2008. 371: 895-7
Advancing the science in clinical trials for new TB drugs
BURMAN, W., ET AL
International Journal of Tuberculosis and Lung Disease. 2008. 12(2): 111-2
Timing of Default From Tuberculosis Treatment: A Systematic Review
KRUK, M., N. SCHWALBE, AND C. AGUIAR
Tropical Medicine and International Health 2008: 5: 703-12
Emerging Drugs for Active Tuberculosis
ANN M. GINSBERG, M.D., PH. D.
Seminars in Respiratory and Critical Care Medicine. 2008. 29(5): 552-559
1
2
3
-
Next
Search:
SEARCH
Media Support Section
click here
For additional information please email:
newsmedia@tballiance.org
TB TREATED LIKE OTHER RESPIRATORY DISEASES IN FUTURE
6/03/2010
Drug-resistant TB risk demands push for new drugs
5/18/2010
China fights growing problem of tuberculosis
1/06/2010
Hopes of new drugs, vaccines for tuberculosis
12/07/2009
New development in TB treatment
6/18/2009
click to view all items
March 2010 Newsletter
November 2009 Newsletter
July 2009 Newsletter
April 2009 Newsletter
December 2008 Newsletter
October 2008 Newsletter
June 2008 Newsletter
click to view all items
© Global Alliance for TB Drug Development, All Rights Reserved